epigallocatechin gallate has been researched along with Benign Neoplasms in 211 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (6.64) | 18.2507 |
| 2000's | 66 (31.28) | 29.6817 |
| 2010's | 103 (48.82) | 24.3611 |
| 2020's | 28 (13.27) | 2.80 |
| Authors | Studies |
|---|---|
| Abramson, HN | 1 |
| Bhat, R; Rotella, DP; Tummalapalli, SR | 1 |
| Arimondo, PB; Erdmann, A; Fahy, J; Halby, L | 1 |
| Chow, LM; Duan, LX; Hu, X; Jiang, T; Li, XM; Liu, T; Liu, Z; Wan, SB; Wang, BC; Wong, IL; Yuan, J; Zhang, XY | 1 |
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Cahlikova, L; Chlebek, J; Havrankova, J; Hofman, J; Hostalkova, A; Lundova, T; Musilek, K; Novotna, E; Wsol, V; Zemanova, L | 1 |
| Chen, L; Jiao, R; Li, X; Liao, W; Ma, X; Wang, Y | 1 |
| Benlloch, M; Castellano, G; Dellinger, RW; Estrela, JM; Mena, S; Obrador, E; Salvador, R | 1 |
| Bi, X; Bian, J; Dai, W; Li, L; Li, Z; Meng, Y; Xu, X | 1 |
| Golonko, A; Lazny, R; Lewandowski, W; Pienkowski, T; Roszko, M; Swislocka, R | 1 |
| Li, L; Wang, L; Xu, XL; You, QD | 1 |
| Kmoníčková, E; Peterková, L; Rimpelová, S; Ruml, T | 1 |
| Cavalli, A; Myers, SH; Ortega, JA | 1 |
| Murphy, PV; Negi, A | 1 |
| Duan, YC; Guan, YY; Yu, T; Zhang, SJ; Zhang, YZ; Zhao, F; Zhao, Y; Zhou, XL | 1 |
| Drummond, E; O'Brien, NM; O'Callaghan, YC; O'Gorman, DM | 1 |
| Chen, S; Kashihara, H; Morine, Y; Nishi, M; Shimada, M; Takasu, C; Tokunaga, T; Wada, Y; Yamada, S | 1 |
| Chen, H; Chen, S; Deng, Y; Li, S; Mao, S; Sun, B; Sun, M; Wu, P; Yin, Y; Zhang, H | 1 |
| Bettuzzi, S; Ferrari, E; Naponelli, V | 1 |
| Alalikhan, A; Hashemian, P; Hashemzadeh, A; Javid, H; Karimi-Shahri, M | 1 |
| Lv, C; Song, J; Wang, D; Yu, X | 1 |
| Feng, K; Li, P; Wang, L | 1 |
| Ban, Q; Chi, W; Granato, D; Hai, D; Huang, X; Wang, S; Wang, X; Zhao, G; Zhao, Q | 1 |
| Alam, M; Ali, N; Celik, I; Dubey, A; Głowacka, P; Kciuk, M; Kontek, R; Rashid, S; Sundaraj, R; Yahya, EB; Zerroug, E | 1 |
| Jia, L; Li, X; Meng, X; Wang, X; Xie, J; Xie, P; Xing, L; Yin, X; Zhao, H; Zhu, W | 1 |
| Alemi, F; Karimian, A; Majidinia, M; Safa, A; Yousefi, B | 1 |
| Sharma, A; Thakur, A; Tuli, HS | 1 |
| Cui, G; Hong, L; Kan, Q; Li, A; Mao, Z; Rao, B; Ren, Z; Sun, R; Sun, S; Yu, Z | 1 |
| Chen, P; Chopra, S; Kaur, D; Li, M; Wang, H; Yang, L; Zhang, W | 1 |
| Chen, TT; Chu, X; Hu, YL; Liu, C; Pan, QS; Yi, JT | 1 |
| Aggarwal, D; Aggarwal, V; Barwal, TS; Bishayee, A; Jain, A; Kaur, G; Pandey, A; Ritzer, EE; Sak, K; Srivastava, S; Tania, M; Tuli, HS; Varol, M | 1 |
| Chen, G; Chen, X; Cui, X; Li, X; Ma, X; Su, W; Sun, Z; Yi, Z | 1 |
| Alhumaydhi, FA; Almatroodi, SA; Almatroudi, A; Alsahli, MA; Khan, AA; Rahmani, AH | 1 |
| Chen, G; Chen, X; Deng, Z; Li, X; Ma, L; Ma, X; Ran, Y; Su, W; Sun, Z; Tong, Q; Yi, Z | 1 |
| Esparza, Y; Machuca, J; Mackenzie, GG; Wei, R; Wirkus, J; Yang, Z | 1 |
| Borriello, A; Cervellera, C; Russo, GL; Stampone, E | 1 |
| Cao, M; Fang, F; Zhang, S | 1 |
| Hayakawa, S; Isemura, M; Miyoshi, N; Nakamura, Y; Ohishi, T; Oishi, Y | 1 |
| Dou, QP; Li, D; Li, F; Qasim, S | 1 |
| Niu, Y; Shen, XJ; Sheng, J; Su, FW; Wang, LX; Wang, XJ; Wang, Y; Wu, YL; Xie, YR; Zhang, DY; Zhang, N; Zi, CT | 1 |
| Abdollahi, M; Bahramsoltani, R; Davatgaran-Taghipour, Y; Farzaei, MH; Karimi-Soureh, Z; Masoomzadeh, S; Rahimi, R | 1 |
| Chu, C; Deng, J; Man, Y; Qu, Y | 1 |
| Fujiki, H; Rawangkan, A; Sueoka, E; Suganuma, M | 1 |
| Fujiki, H; Rawangkan, A; Sueoka, E; Suganuma, M; Watanabe, T | 1 |
| Chan, TH; Chen, Y; Dou, QP; Fardous, R; Lewandowski, A; Li, D; Li, F; Liu, J; Qiao, X; Wang, Y | 1 |
| Ding, S; Fang, J; Jiang, H | 1 |
| Chao, CY; Chen, WT; Hsieh, CH; Kuo, YY; Lu, CH | 1 |
| Yang, CS; Zhang, J | 1 |
| Bettuzzi, S; Naponelli, V; Negri, A; Rizzi, F | 1 |
| Kong, D; Liang, J; Ma, G; Wang, C; Wang, X; Zhang, C | 1 |
| Eisenstein, M | 1 |
| Chen, T; Fang, J; Fang, S; Hong, H; Jian, W; Li, D; Liu, W; Mo, Y; Shen, J; Song, L; Wang, Q; Xia, Y; Xiong, S | 1 |
| Arnold, M; Huang, YW; Oshima, K; Pan, P; Wang, LS; Yearsley, M; Yu, J; Zhang, J | 1 |
| Du, L; Li, X; Wang, W; Xiong, X; Yang, W; Zhang, Q | 1 |
| Cai, C; Guo, Q; Han, J; Liu, J; Liu, M; Shi, Y; Wu, Y; Zhao, Y | 1 |
| Chen, Z; Ma, G; Sun, H; Wang, X; Wei, X; Yang, J; Zhang, C | 1 |
| He, Y; Reiter, RJ; Wu, X; Yang, CS; Zhang, J; Zhang, K; Zhang, L; Zhao, G | 1 |
| Jia, Q; Li, L; Liu, Y; Zhang, G; Zhou, J | 1 |
| Donejko, M; Galicka, E; Niczyporuk, M; Przylipiak, A | 1 |
| Dupertuis, YM; Lecumberri, E; Miralbell, R; Pichard, C | 1 |
| Gerhauser, C | 1 |
| Arbiser, JL; Bonner, MY; Brady, C; Hawkins, AR; Lamb, HK; Lefkove, B; Lovat, PE; Martin, S; Redfern, CP; Thompson, P | 1 |
| Li, Y; Sarkar, FH; Sethi, S | 1 |
| Chen, M; Wang, S; Wang, Y; Zhang, J | 1 |
| Lorenz, M | 1 |
| Carpenter, CL; Heber, D; Henning, SM; Wang, P | 1 |
| Hu, G; Ni, X; Rong, Y; Sun, Y; Zhang, L | 1 |
| Doi, S; Harui, K; Higashino, Y; Ishihara, S; Kawasaki, T; Nakajima, N; Okamoto, S; Okamoto, T; Saito, A | 1 |
| Iseki, K; Kobayashi, M; Ogura, J; Satoh, T; Takahashi, N; Watanabe, K; Yamaguchi, H | 1 |
| Wei, Y; Zhang, J; Zhang, L | 1 |
| Aras, A; Farooqi, AA; Hechenleitner, AA; Khokhar, AR; Pineda, EA; Qureshi, MZ; Silva, MF; Sobczak-Kupiec, A | 1 |
| Han, M; Lu, W; Qiao, J; Shang, W | 1 |
| Nagoor, NH; Phuah, NH | 1 |
| Choi, HS; Chung, JE; Gao, SJ; Kim, SH; Kurisawa, M; Lee, JH; Tan, S; Yano, H; Ying, JY; Yongvongsoontorn, N; Zhuo, L | 1 |
| Blagg, BS; Forsberg, LK; Hall, JA | 1 |
| Camara, LE; Ferreira, LR; Gambero, A; Macedo, GA; Macedo, JA; Ribeiro, ML; Santos, JC | 1 |
| Arumuggam, N; Bhowmick, NA; Rupasinghe, HP | 1 |
| Al Shabrmi, FM; Allemailem, KS; Aly, SM; Khan, MA; Rahmani, AH | 1 |
| Dobos, A; Horvath, R; Juhasz, K; Körösi, L; Nador, J; Patko, D; Peter, B; Székács, I | 1 |
| Elbaz, HA; Hüttemann, M; Lee, I; Malek, MH; Shay, J; Zielske, SP | 1 |
| Khan, M; Ma, T; Maryam, A; Mehmood, T; Zhang, Y | 1 |
| Colomer, R; Lupu, R; Puig, T; Sarrats, A | 1 |
| Janakiram, NB; Kumar, G; Madka, V; Mohammed, A; Rao, CV | 1 |
| Iketaki, K; Ito, K; Kakinuma, E; Kobayashi, N; Masuda, K; Matsuzaki, T; Nakabayashi, S; Sakamoto, R; Suganuma, M; Tanii, T; Yamamoto, H; Yoshikawa, HY | 1 |
| Ghosh, M; Jeong, DK; Park, YH; Sharma, N; Singh, AK | 1 |
| Sanna, V; Siddiqui, IA | 1 |
| Bayliss, R; Brown, K; Gescher, A; Howells, L; Karmokar, A; Khan, S; Thomas, AL | 1 |
| Alibakhshi, A; Mollazade, M; Nasiri, M; Pilehvar-Soltanahmadi, Y; Ranjbari, J; Zarghami, N | 1 |
| Granja, A; Pinheiro, M; Reis, S | 1 |
| Dhatwalia, SK; Dhawan, DK; Kumar, M | 1 |
| Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
| Goto, S; Isemura, M; Monira, P; Nakamura, Y; Ohishi, T | 1 |
| Corke, H; Gan, RY; Li, HB; Sui, ZQ | 1 |
| Eitsuka, T; Miyazawa, T; Nakagawa, K; Nishida, H; Tatewaki, N | 1 |
| Fujiki, H; Iida, K; Matsuzaki, T; Suganuma, M; Takahashi, A; Watanabe, T; Yoshikawa, HY | 1 |
| Wang, H; Yang, CS | 1 |
| Begun, J; De, R; Popat, A; Tyagi, N | 1 |
| Bishayee, A; Daglia, M; Nabavi, SF; Nabavi, SM; Pandima Devi, K; Rajavel, T | 1 |
| Sliva, D | 1 |
| Castro, DJ; Dashwood, RH; Fischer, KA; Giovanini, JN; Löhr, CV; Orner, GA; Pereira, CB; Williams, DE; Yu, Z | 1 |
| Tachibana, H | 3 |
| Bolt, HM; Hengstler, JG; Marchan, R | 1 |
| Sun, W; Wang, GS; Xu, LB; Xu, Y; Yang, XH | 1 |
| Bettuzzi, S; Patra, SK; Rizzi, F; Rugina, DO; Silva, A | 1 |
| Kong, D; Li, Y; Sarkar, FH; Wang, Z | 1 |
| Hescheler, J; Jagtap, S; Meganathan, K; Sachinidis, A; Wagh, V; Winkler, J | 1 |
| Bode, AM; Dong, Z | 1 |
| Lu, G; Picinich, SC; Wang, X; Yang, CS | 1 |
| Manson, MM; Moiseeva, EP | 1 |
| Amici, M; Angeletti, M; Bonfili, L; Cecarini, V; Cuccioloni, M; Eleuteri, AM; Fioretti, E; Giuliani, L; Grimaldi, S | 1 |
| Mukhtar, H; Siddiqui, IA | 1 |
| Dominiak, K; Heilbrun, LK; McKinney, J; Sarkar, FH | 1 |
| Li, Y; Tollefsbol, TO | 1 |
| Elias, RJ; Lambert, JD | 1 |
| Aslan, A; Dogukan, A; Gencoglu, H; Kucuk, O; Sahin, K; Sahin, N; Timurkan, M; Tuzcu, M | 1 |
| Argilés, JM; Barberis, P; Busquets, S; Figueras, M; Fontes de Oliveira, C; López-Soriano, FJ; Olivan, M; Sette, A; Toledo, M; Ventura da Silva, P | 1 |
| Kalinovsky, T; Monterrey, JC; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
| Adhami, VM; Ahmad, N; Mukhtar, H; Siddiqui, IA | 1 |
| Wang, X; Yang, CS | 1 |
| Luo, HM; Sun, W; Yang, XH; Yin, JY | 1 |
| Cheng, IC; Lee, TC; Shue, JJ; Wang, TC | 1 |
| Fujiki, H; Saha, A; Suganuma, M | 1 |
| Kannaiyan, R; Sethi, G; Shanmugam, MK | 1 |
| Li, Y; Schwartz, SJ; Sun, D; Wicha, MS | 1 |
| Backer, JM; Backer, MV; Chinnaiyan, P | 1 |
| Chan, TH; Chen, D; Dou, QP; Wan, SB; Yang, H; Yuan, J | 1 |
| Du, J; Gu, C; Han, M; Lu, W; Qiao, J; Shang, W; Wang, W; Yin, W; Zhu, M | 1 |
| Ho, YS; Lee, CH; Wu, CH | 1 |
| Chiou, YS; Ho, CT; Lin, JK; Pan, MH; Wang, YJ | 1 |
| Shankar, S; Singh, BN; Srivastava, RK | 1 |
| Marnett, LJ; Rouzer, CA | 1 |
| Bojjireddy, N; Datta, A; Patel, RY; Sinha, RK; Subrahmanyam, G | 1 |
| Sommer, AP | 1 |
| Hardy, TM; Tollefsbol, TO | 1 |
| Russo, GL; Russo, M; Spagnuolo, C; Tedesco, I | 1 |
| Cassileth, B | 1 |
| Heber, D; Henning, SM; Wang, P | 1 |
| Bang, H; Choi, JH; Ham, SW; Kim, JH; Ko, YJ; Lee, KH; Liang, W; Min, NY; Park, AJ; Rhee, S | 1 |
| Taylor, EW; Wan, X; Wang, D; Wang, Y; Zhang, J | 1 |
| Fujiki, H; Suganuma, M | 1 |
| Müller, J; Pfaffl, MW | 1 |
| Huang, Y; Kim, Y; Kumazoe, M; Suemasu, Y; Sugihara, K; Suzuki, T; Tachibana, H; Tsukamoto, S; Tsurudome, Y; Ueda, N; Yamada, K; Yamashita, S | 1 |
| Fujiki, H; Imai, K; Nakachi, K; Suganuma, M | 1 |
| Frei, B; Higdon, JV | 1 |
| Bollag, WB; Dickinson, D; Hsu, S; Lewis, J; Lockwood, P; Osaki, T; Schuster, G; Singh, B; Ueta, E; Wataha, J; Yamamoto, T | 1 |
| Chung, FL; Herzog, CR; Schwartz, J; Yang, YM | 1 |
| Conney, AH | 1 |
| Borska, S; Drag-Zalesińska, M; Gebarowska, E; Wysocka, T; Zabel, M | 1 |
| Park, OJ; Surh, YJ | 1 |
| Hong, J; Hou, Z; Sang, S; Yang, CS | 1 |
| Arjmandi, BH; Tripathi, P; Tripathi, YB | 1 |
| Doss, MX; Hescheler, J; Potta, SP; Sachinidis, A | 1 |
| Anglard, P; El Bedoui, J; Oak, MH; Schini-Kerth, VB | 1 |
| Fujiki, H | 2 |
| Manson, MM | 1 |
| Kundu, JK; Surh, YJ | 1 |
| Band, MA; Guo, W; Liu, L; Meydani, M; Paulson, EK; Rodriguez, SK | 1 |
| D'Incalci, M; Gescher, AJ; Steward, WP | 1 |
| Kundu, JK; Lee, JS; Na, HK; Surh, YJ | 1 |
| Hou, Z; Ju, J; Lambert, JD; Lu, G; Sang, S; Yang, CS | 1 |
| Na, HK; Surh, YJ | 1 |
| Wu, AH; Yu, MC | 1 |
| Doss, MX; Hescheler, J; Mariappan, D; Parthiban, V; Sachinidis, A; Winkler, J | 1 |
| Lee, HJ; Lee, KW | 1 |
| Ferreira, D; Nagle, DG; Zhou, YD | 1 |
| Yang, CS | 1 |
| Dou, QP | 1 |
| Aruoma, OI; Bahorun, T; Soobrattee, MA | 1 |
| Bayer, DK; Beltz, LA; Moss, AL; Simet, IM | 1 |
| James Morré, D; Kuntz, CP; Morré, DM; Wu, LY; Yagiz, K | 1 |
| Berry, DP; Garcea, G; Gescher, AJ; Marczylo, T; Steward, WP; Thomasset, SC | 1 |
| Narayanan, BA | 1 |
| Chan, TH; Chen, D; Dou, QP; Landis-Piwowar, KR; Milacic, V; Yan, B; Yang, H; Zhao, Y | 1 |
| Ju, J; Lambert, JD; Lu, G; Sang, S; Yang, CS | 1 |
| Bauer, BA; Carlson, JR; Limburg, PJ; Vincent, A; Wilson, T | 1 |
| Han, HD; Kang, TH; Kim, JH; Kim, TW; Noh, KH; Park, ES; Park, YS; Shin, BC; Song, CK | 1 |
| Ganapathy, S; Shankar, S; Srivastava, RK | 1 |
| Kane, SE; Sadava, D; Whitlock, E | 1 |
| Ju, J; Lambert, JD; Lu, G; Yang, CS | 1 |
| Bonnet, N; Delavoie, F; Zahm, JM | 1 |
| Andreadi, CK; Foreman, BE; Howells, LM; Hudson, EA; Manson, MM; Moiseeva, EP; Neal, CP; Sun, YY | 1 |
| Chen, L; Zhang, HY | 1 |
| Katiyar, SK; Meeran, SM | 1 |
| Gescher, AJ; Steward, WP; Verschoyle, RD | 1 |
| Almeida, GM; Jones, GD; Manson, MM; Moiseeva, EP | 1 |
| Fujiki, H; Kuzuhara, T; Suganuma, M | 1 |
| Khan, N; Mukhtar, H | 1 |
| Fujiki, H; Komori, A; Ohta, T; Okabe, S; Sueoka, E; Suganuma, M; Yatsunami, J | 1 |
| Arimoto, S; Hayatsu, H; Negishi, T | 1 |
| Fujiki, H; Komori, A; Kozu, T; Okabe, S; Sakai, Y; Sueoka, E; Sueoka, N; Suganuma, M | 1 |
| Jankun, J; Selman, SH; Skrzypczak-Jankun, E; Swiercz, R | 1 |
| Fujiki, H; Imai, K; Komori, A; Kozu, T; Nakachi, K; Okabe, S; Sueoka, E; Sueoka, N; Suga, K; Suganuma, M; Tada, Y | 1 |
| Naasani, I; Seimiya, H; Tsuruo, T | 1 |
| Chen, KY; Chen, ZP; Ho, CT; Schell, JB | 1 |
| Fujiki, H; Imai, K; Kimura, S; Nakachi, K; Okabe, S; Sueoka, E; Suga, K; Suganuma, M | 1 |
| Surh, Y | 1 |
| Fujiki, H; Imai, K; Matsuyama, S; Nakachi, K; Okabe, S; Sueoka, E; Sueoka, N; Suganuma, M | 1 |
| Brown, MD | 1 |
| Bradlow, HL; Osborne, MP; Sepkovic, DW; Telang, NT | 1 |
| Fujiki, H; Imai, K; Nakachi, K; Okabe, S; Sueoka, E; Suga, K; Suganuma, M | 1 |
| Webb, T | 1 |
| Menon, SR; Mitscher, LA; Pillai, CA; Pillai, SP; Shankel, DM; Telikepalli, H | 1 |
| Dong, Z | 1 |
| Aoyagi, Y; Hayakawa, S; Isemura, M; Kimura, T; Koyama, Y; Nakamura, Y; Noro, T; Saeki, K | 1 |
| Albini, A; De Flora, S; Ferrari, N; Tosetti, F | 1 |
| Ellis, LM; Jung, YD | 1 |
| Bartsch, H; Bertram, B | 1 |
130 review(s) available for epigallocatechin gallate and Benign Neoplasms
| Article | Year |
|---|---|
Progress in the discovery and development of heat shock protein 90 (Hsp90) inhibitors.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Drug Design; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Neoplasms; Neuroprotective Agents; Protein Isoforms; Rats; tau Proteins | 2014 |
Targeting DNA methylation with small molecules: what's next?
Topics: Animals; Antineoplastic Agents; DNA Methylation; DNA Modification Methylases; Drug Discovery; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Molecular Targeted Therapy; Neoplasms; Nucleosides | 2015 |
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Discovery and development of small molecule modulators targeting glutamine metabolism.
Topics: Animals; Antineoplastic Agents; Drug Discovery; Energy Metabolism; Glutamine; Humans; Neoplasms | 2019 |
Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system.
Topics: Animals; Diet; Humans; Neoplasms; Phenols; Polyphenols; Proteasome Endopeptidase Complex; Ubiquitin | 2019 |
Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions.
Topics: Animals; Antineoplastic Agents; Autoimmune Diseases; Benzoquinones; Forecasting; HSP90 Heat-Shock Proteins; Humans; Immunosuppressive Agents; Lactams, Macrocyclic; Molecular Chaperones; Neoplasms; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary | 2020 |
Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective.
Topics: Animals; Antineoplastic Agents; Enzyme Inhibitors; Gene Regulatory Networks; Humans; Neoplasms; Protein Structure, Secondary; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2020 |
Synthetic Lethality through the Lens of Medicinal Chemistry.
Topics: Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cyclin-Dependent Kinases; DNA-Activated Protein Kinase; Genes, BRCA2; Humans; Neoplasms; Poly(ADP-ribose) Polymerases; Precision Medicine; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Rad51 Recombinase; Synthetic Lethal Mutations | 2020 |
Development of Mcl-1 inhibitors for cancer therapy.
Topics: Antineoplastic Agents; Cell Proliferation; Drug Development; Heterocyclic Compounds; Humans; Molecular Structure; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasms | 2021 |
Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs.
Topics: Ectoderm; Enhancer of Zeste Homolog 2 Protein; Humans; Intercellular Signaling Peptides and Proteins; Neoplasms; Polycomb Repressive Complex 2 | 2022 |
The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment: A Narrative Review.
Topics: Apoptosis; Autophagy; Catechin; Humans; Neoplasms; Phosphatidylinositol 3-Kinases; Tea | 2022 |
The applications of epigallocatechin gallate (EGCG)-nanogold conjugate in cancer therapy.
Topics: Biological Availability; Catechin; Drug Delivery Systems; Humans; Neoplasms; Tea | 2023 |
EGCG adjuvant chemotherapy: Current status and future perspectives.
Topics: Adjuvants, Immunologic; Animals; Apoptosis; Catechin; Cell Line, Tumor; Cisplatin; Doxorubicin; Mice; Neoplasms; Quality of Life | 2023 |
Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications.
Topics: Apoptosis; Catechin; Humans; Neoplasms; NF-kappa B; Phosphatidylinositol 3-Kinases; Signal Transduction; Tea | 2023 |
Targeting miRNAs by polyphenols: Novel therapeutic strategy for aging.
Topics: Aging; Cardiovascular Diseases; Catechin; Gene Expression Regulation; Humans; Longevity; MicroRNAs; Neoplasms; Nervous System Diseases; Polyphenols | 2020 |
The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer.
Topics: Anticarcinogenic Agents; Catechin; Cell Line, Tumor; DNA Modification Methylases; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Humans; MicroRNAs; Neoplasms | 2020 |
Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement.
Topics: Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Humans; Neoplasms; Prospective Studies; Reproducibility of Results | 2022 |
Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Catechin; Cell Proliferation; Drug Carriers; Humans; Nanostructures; Neoplasms; Signal Transduction; Tea | 2020 |
Regulation of p27
Topics: Antineoplastic Agents, Phytogenic; Catechin; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinase Inhibitor p57; Cytoplasm; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Proteasome Endopeptidase Complex; Protein Domains; Proteolysis; Resveratrol | 2020 |
The Role of Epigallocatechin-3-Gallate in Autophagy and Endoplasmic Reticulum Stress (ERS)-Induced Apoptosis of Human Diseases.
Topics: Apoptosis; Autophagy; Cardiovascular Diseases; Catechin; Diabetes Mellitus; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Humans; Neoplasms; Nervous System Diseases; Signal Transduction | 2020 |
Anti-Cancer Effects of Green Tea Epigallocatchin-3-Gallate and Coffee Chlorogenic Acid.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Catechin; Chlorogenic Acid; Coffee; Humans; Neoplasms; Tea | 2020 |
Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator.
Topics: Catechin; Epigenesis, Genetic; Humans; Neoplasms; Polyphenols; Tea | 2022 |
Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective.
Topics: Antineoplastic Agents; Antioxidants; Biological Availability; Catechin; Curcumin; Drug Delivery Systems; Humans; Nanocomposites; Nanoparticles; Neoplasms; Polyphenols; Quercetin; Resveratrol; Stilbenes | 2017 |
Green Tea Extracts Epigallocatechin-3-gallate for Different Treatments.
Topics: Antioxidants; Catechin; Humans; Inflammation; Neoplasms; Polyphenols; Tea | 2017 |
Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate.
Topics: Animals; Biomarkers, Tumor; Catechin; Humans; Neoplasms; Neoplastic Stem Cells | 2017 |
Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells.
Topics: Animals; Catechin; Cell Movement; Clinical Trials as Topic; Humans; Mice; Neoplasms; Neoplastic Stem Cells; Phytotherapy; Tea | 2018 |
Perspectives on the recent developments with green tea polyphenols in drug discovery.
Topics: Animals; Anticarcinogenic Agents; Catechin; Drug Discovery; Humans; Nanoparticles; Neoplasms; Polyphenols; Prodrugs; Tea | 2018 |
Regulation of Immune Function by Polyphenols.
Topics: Animals; Catechin; Curcumin; Epigenesis, Genetic; Humans; Hypersensitivity; Immunity; Immunomodulation; Inflammation; Neoplasms; Nutritional Physiological Phenomena; Oxidative Stress; Polyphenols; Signal Transduction | 2018 |
Studies on the Prevention of Cancer and Cardiometabolic Diseases by Tea: Issues on Mechanisms, Effective Doses, and Toxicities.
Topics: Animals; Camellia sinensis; Cardiovascular Diseases; Catechin; Humans; Neoplasms; Randomized Controlled Trials as Topic; Tea | 2019 |
Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and Cancer.
Topics: Camellia sinensis; Catechin; DNA Methylation; Humans; Metalloproteases; Methyltransferases; Neoplasms; NIMA-Interacting Peptidylprolyl Isomerase; Phytotherapy; Plant Extracts; Polyphenols; Receptors, Cell Surface; Signal Transduction; Tea | 2018 |
The immunomodulatory potential of natural compounds in tumor-bearing mice and humans.
Topics: Animals; beta-Glucans; Carotenoids; Catechin; Curcumin; Humans; Immune System; Immunologic Factors; Killer Cells, Natural; Mice; Neoplasms; Resveratrol; T-Lymphocytes; Tretinoin; Tumor Microenvironment | 2019 |
[Anti-cancer properties epigallocatechin-gallate contained in green tea].
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Breast Neoplasms; Catechin; Cell Transformation, Neoplastic; Female; Gastrointestinal Neoplasms; Humans; Male; Neoplasms; Skin Neoplasms; Tea | 2013 |
Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Cycle; Chemotherapy, Adjuvant; Humans; Neoplasms; Neovascularization, Pathologic; Polyphenols; Tea | 2013 |
Epigenetic impact of dietary isothiocyanates in cancer chemoprevention.
Topics: Animals; Anticarcinogenic Agents; Brassica; Catechin; Chemoprevention; Diet; DNA Methylation; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Intracellular Signaling Peptides and Proteins; Isothiocyanates; Kelch-Like ECH-Associated Protein 1; MicroRNAs; Neoplasms; NF-E2-Related Factor 2; Signal Transduction; Sulfoxides | 2013 |
Regulating miRNA by natural agents as a new strategy for cancer treatment.
Topics: Animals; Antineoplastic Agents; Carotenoids; Catechin; Curcumin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Lycopene; MicroRNAs; Molecular Targeted Therapy; Neoplasms; Neoplastic Stem Cells; Resveratrol; Stilbenes | 2013 |
Delivering flavonoids into solid tumors using nanotechnologies.
Topics: Animals; Antineoplastic Agents; Biological Availability; Catechin; Drug Delivery Systems; Flavonoids; Genistein; Humans; Nanotechnology; Neoplasms; Quercetin | 2013 |
Epigenetic effects of green tea polyphenols in cancer.
Topics: Animals; Bone Morphogenetic Protein 2; Catechin; CDX2 Transcription Factor; Diet; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Neoplasms; Polyphenols; Tea; Trans-Activators | 2013 |
Downstream carcinogenesis signaling pathways by green tea polyphenols: a translational perspective of chemoprevention and treatment for cancers.
Topics: Animals; Anticarcinogenic Agents; Camellia sinensis; Carcinogenesis; Catechin; Humans; Neoplasms; Polyphenols; Signal Transduction | 2014 |
Novel mechanisms of anticancer activities of green tea component epigallocatechin- 3-gallate.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Catechin; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; Neoplasms; Phosphodiesterase 5 Inhibitors; Plant Extracts; Tea | 2014 |
Targeting cancer with nano-bullets: curcumin, EGCG, resveratrol and quercetin on flying carpets.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Catechin; Cell Proliferation; Cell Transformation, Neoplastic; Curcumin; Drug Carriers; Humans; Lactic Acid; Mice; Nanoparticles; Neoplasms; Phytochemicals; Polyglycolic Acid; Polyhydroxyethyl Methacrylate; Polylactic Acid-Polyglycolic Acid Copolymer; Quercetin; Resveratrol; Silicon Dioxide; Stilbenes; Xenograft Model Antitumor Assays | 2014 |
The interactions of anticancer agents with tea catechins: current evidence from preclinical studies.
Topics: Animals; Antineoplastic Agents; Catechin; Drug Synergism; Food-Drug Interactions; Humans; Neoplasms; Tea | 2014 |
Regulation of microRNAs by natural agents: new strategies in cancer therapies.
Topics: Antineoplastic Agents; Biological Products; Biomarkers, Tumor; Catechin; Curcumin; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Neoplasms; Resveratrol; RNA Stability; Stilbenes | 2014 |
A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer.
Topics: Animals; Catechin; Cell Proliferation; Cucurbitacins; Curcumin; Disease Models, Animal; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Janus Kinases; Neoplasms; Phytochemicals; Resveratrol; Signal Transduction; STAT Transcription Factors; Stilbenes | 2015 |
Implications of Green Tea and Its Constituents in the Prevention of Cancer via the Modulation of Cell Signalling Pathway.
Topics: Apoptosis; Catechin; China; Humans; Japan; Neoplasms; Saudi Arabia; Signal Transduction; Tea | 2015 |
Molecular Mechanisms and Therapeutic Effects of (-)-Epicatechin and Other Polyphenols in Cancer, Inflammation, Diabetes, and Neurodegeneration.
Topics: Catechin; Humans; Inflammation; Mitochondria; Neoplasms; Neurodegenerative Diseases; Polyphenols; Reactive Oxygen Species; Signal Transduction | 2015 |
Enhancing Activity of Anticancer Drugs in Multidrug Resistant Tumors by Modulating P-Glycoprotein through Dietary Nutraceuticals.
Topics: Abietanes; Alkaloids; Allyl Compounds; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Benzodioxoles; beta Carotene; Biflavonoids; Capsaicin; Catechin; Catechols; Curcumin; Dietary Supplements; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Fatty Alcohols; Furocoumarins; Humans; Indoles; Limonins; Neoplasms; Phytotherapy; Piperidines; Polyunsaturated Alkamides; Proanthocyanidins; Quercetin; Resveratrol; Stilbenes; Sulfides; Tea; Triterpenes; Xanthophylls | 2015 |
Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents.
Topics: Animals; Anticarcinogenic Agents; Catechin; Clinical Trials as Topic; Humans; Neoplasms; Polyphenols; Signal Transduction; Structure-Activity Relationship; Tea | 2017 |
Prevention and treatment of cancers by immune modulating nutrients.
Topics: Animals; Arginine; Catechin; Cell Line, Tumor; Diet; Disease Models, Animal; Fatty Acids, Unsaturated; Glutamine; Humans; Isothiocyanates; Lignans; Meta-Analysis as Topic; Micronutrients; Neoplasms; Observational Studies as Topic; Phytochemicals; Polyphenols; Randomized Controlled Trials as Topic; Stilbenes | 2016 |
Emerging importance of dietary phytochemicals in fight against cancer: Role in targeting cancer stem cells.
Topics: Catechin; Humans; Neoplasms; Neoplastic Stem Cells; Phytochemicals | 2017 |
Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy.
Topics: Animals; Anticarcinogenic Agents; Biological Products; Catechin; Cell Line, Tumor; Chemoprevention; Curcumin; Disease Models, Animal; Humans; Nanoparticles; Nanotechnology; Neoplasms; Resveratrol; Stilbenes | 2016 |
Targeting cancer stem-like cells using dietary-derived agents - Where are we now?
Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Curcumin; Diet; Disease Models, Animal; Flavonoids; Humans; Isothiocyanates; Neoplasms; Neoplastic Stem Cells; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes; Sulfoxides; Vitamin A | 2016 |
An Update on Phytochemicals in Molecular Target Therapy of Cancer: Potential Inhibitory Effect on Telomerase Activity.
Topics: Anticarcinogenic Agents; Catechin; Curcumin; Drug Compounding; Humans; Neoplasms; Phytochemicals; Polyphenols; Telomerase | 2016 |
Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Catechin; Drug Carriers; Drug Compounding; Drug Delivery Systems; Humans; Nanomedicine; Nanoparticles; Neoplasms | 2016 |
Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis.
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Artemisinins; Catechin; Cell Proliferation; Curcumin; Humans; Neoplasms; Neovascularization, Pathologic; Plant Extracts; Resveratrol; Stilbenes; Triterpenes | 2016 |
Anticancer Efficacy of Polyphenols and Their Combinations.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Biological Availability; Catechin; Cell Line, Tumor; Cell Proliferation; Curcumin; Disease Models, Animal; Humans; Micronutrients; Neoplasms; Plant Extracts; Polyphenols; Quercetin; Resveratrol; Stilbenes; Tea | 2016 |
Anti-inflammatory Action of Green Tea.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Camellia sinensis; Cardiovascular Diseases; Catechin; Diabetes Mellitus; Humans; Inflammation Mediators; Neoplasms; Neurodegenerative Diseases; Obesity; Reactive Oxygen Species; Tea | 2016 |
Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review.
Topics: Animals; Antineoplastic Agents; Catechin; Cell Line, Tumor; Drug Synergism; Humans; Neoplasms; Neoplastic Stem Cells; Polyphenols; Tea | 2018 |
Synergistic Anticancer Effect of Tocotrienol Combined with Chemotherapeutic Agents or Dietary Components: A Review.
Topics: Antineoplastic Agents; Catechin; Coumaric Acids; Dietary Supplements; Dioxoles; Drug Synergism; Drug Therapy, Combination; Humans; Lignans; Neoplasms; Resveratrol; Stilbenes; Tocotrienols | 2016 |
Biophysical Approach to Mechanisms of Cancer Prevention and Treatment with Green Tea Catechins.
Topics: Animals; Biochemical Phenomena; Catechin; Cell Movement; Humans; Microfluidics; Microscopy, Atomic Force; Neoplasms; Optical Phenomena; Plant Extracts; Tea | 2016 |
Cancer Preventive Activities of Tea Catechins.
Topics: Animals; Apoptosis; Catechin; Cell Proliferation; Cell Transformation, Neoplastic; Humans; Neoplasms; Neovascularization, Pathologic; Tea | 2016 |
Cancer therapeutics with epigallocatechin-3-gallate encapsulated in biopolymeric nanoparticles.
Topics: Animals; Anticarcinogenic Agents; Biopolymers; Catechin; Humans; Nanoparticles; Neoplasms | 2017 |
Targeting miRNAs by polyphenols: Novel therapeutic strategy for cancer.
Topics: Catechin; Curcumin; Gene Expression Regulation, Neoplastic; Genistein; Humans; MicroRNAs; Neoplasms; Polyphenols; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Suppression of cancer invasiveness by dietary compounds.
Topics: Animals; Antineoplastic Agents; Catechin; Drugs, Chinese Herbal; Genistein; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Reishi; Signal Transduction; Structure-Activity Relationship; Tea | 2008 |
Green tea polyphenol EGCG signaling pathway through the 67-kDa laminin receptor.
Topics: Animals; Apoptosis; Camellia sinensis; Catechin; Cell Division; Eukaryotic Initiation Factor-1; Histamine Release; Humans; Neoplasms; Receptors, IgE; Receptors, Laminin; Signal Transduction | 2008 |
[Progress in the studies on small molecule IGF-1R inhibitors].
Topics: Animals; Apoptosis; Benzimidazoles; Catechin; Cell Line, Tumor; Humans; Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyridones; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Signal Transduction | 2008 |
Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts.
Topics: Animals; Antineoplastic Agents; Apoptosis; Camellia sinensis; Catechin; Drug Delivery Systems; Humans; Membrane Microdomains; Mitogen-Activated Protein Kinases; Neoplasms; Tea | 2008 |
Cellular signaling perturbation by natural products.
Topics: Antineoplastic Agents; Carotenoids; Catechin; Curcumin; Humans; Indoles; Isoflavones; Lycopene; Neoplasms; Resveratrol; Signal Transduction; Stilbenes | 2009 |
Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases.
Topics: Anticarcinogenic Agents; Antioxidants; Cardiovascular Diseases; Catechin; Curcumin; Humans; Models, Biological; Molecular Structure; Neoplasms; Oxidative Stress; Quercetin | 2009 |
Molecular basis for cancer chemoprevention by green tea polyphenol EGCG.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Catechin; Chemoprevention; Flavonoids; Humans; Mice; Neoplasms; Phenols; Polyphenols; Receptors, Laminin; Tea | 2009 |
Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail.
Topics: Adenoma; Aerosols; Animals; Anticarcinogenic Agents; Antioxidants; Benzo(a)pyrene; Biological Availability; Catechin; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Flavonoids; Humans; Lung Neoplasms; Mice; Mice, Inbred A; Models, Biological; Neoplasms; Phenols; Phytotherapy; Polyphenols; Protein Binding; Tea | 2009 |
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance.
Topics: Animals; Anticarcinogenic Agents; Catechin; Humans; Neoplasms; Phytotherapy; Plant Extracts; Tea | 2009 |
Dietary chemopreventive phytochemicals: too little or too much?
Topics: Animals; Catechin; Cell Transformation, Neoplastic; Curcumin; Diet; Food; Fruit; Genistein; Humans; Indoles; Mice; Models, Biological; Neoplasms; Phytotherapy; Vegetables | 2009 |
Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Catechin; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Genistein; Humans; Isothiocyanates; Neoplasms; Selenium | 2010 |
The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Apoptosis; Catalysis; Catechin; Cell Proliferation; Chelating Agents; Flavonoids; Humans; Models, Biological; Neoplasms; Oxidants; Oxidation-Reduction; Phenols; Polyphenols; Signal Transduction; Tea; Trace Elements | 2010 |
Nanochemoprevention: sustained release of bioactive food components for cancer prevention.
Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Proliferation; Delayed-Action Preparations; Humans; Nanocapsules; Nanoparticles; Neoplasms | 2010 |
Green tea and cancer prevention.
Topics: Animals; Anticarcinogenic Agents; Catechin; Enzyme Inhibitors; Humans; Neoplasms; Tea | 2010 |
[Progress in the study of heat shock protein 90 inhibitors].
Topics: Adenine; Animals; Anisoles; Antineoplastic Agents; Benzoquinones; Catechin; Cell Line, Tumor; Crystallization; Heterocyclic Compounds, 2-Ring; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Macrolides; Molecular Structure; Neoplasms; Pyrazoles; Structure-Activity Relationship | 2010 |
New cancer treatment strategy using combination of green tea catechins and anticancer drugs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Catechin; Humans; Neoplasms; Phytotherapy; Plant Extracts; Tea | 2011 |
Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Catechin; Clinical Trials as Topic; Curcuma; Curcumin; Diet; Disease Models, Animal; Fruit; Genistein; Humans; Neoplasms; Resveratrol; Signal Transduction; Silymarin; Stilbenes; United States; Vegetables | 2011 |
Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds.
Topics: Alkaloids; Animals; Anticarcinogenic Agents; Benzodioxoles; beta Catenin; Carotenoids; Catechin; Cell Differentiation; Cell Proliferation; Cholecalciferol; Curcumin; Diet; Humans; Isoflavones; Isothiocyanates; Lycopene; Neoplasms; Neoplastic Stem Cells; Piperidines; Polyunsaturated Alkamides; Resveratrol; Signal Transduction; Stilbenes; Sulfoxides; Thiocyanates; Wnt Proteins | 2011 |
EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment.
Topics: Anticarcinogenic Agents; Catechin; DNA Damage; DNA Methylation; Flavonoids; Humans; Neoplasms; Phenols; Polyphenols; Prodrugs; Proteasome Inhibitors; Structure-Activity Relationship; Tea | 2011 |
Green tea polyphenol sensing.
Topics: Animals; Catechin; Humans; Hypersensitivity; Inflammation; Neoplasms; Receptors, Laminin; Tea | 2011 |
Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Catechin; Humans; Neoplasms; Signal Transduction; Tea | 2011 |
Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Camellia sinensis; Catechin; Cell Proliferation; Cell Transformation, Neoplastic; Humans; Molecular Structure; Neoplasms; Signal Transduction | 2011 |
Epigenetic diet: impact on the epigenome and cancer.
Topics: Anticarcinogenic Agents; Catechin; Curcumin; Diet; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Epigenesis, Genetic; Epigenomics; Genistein; Histones; Humans; Isothiocyanates; MicroRNAs; Neoplasms; Polyphenols; Resveratrol; Stilbenes; Tea | 2011 |
Phytochemicals in cancer prevention and therapy: truth or dare?
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Carotenoids; Catechin; Curcumin; Genistein; Humans; Isothiocyanates; Lycopene; Neoplasms; Resveratrol; Stilbenes | 2010 |
Encapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention.
Topics: Animals; Anticarcinogenic Agents; Catechin; Cattle; Chemoprevention; Humans; Metal Nanoparticles; Mice; Nanocapsules; Nanomedicine; Neoplasms; Selenium; Selenoproteins; Serum Albumin, Bovine | 2012 |
Green tea: an effective synergist with anticancer drugs for tertiary cancer prevention.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Catechin; Cell Line, Tumor; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasms; Receptors, TNF-Related Apoptosis-Inducing Ligand; Tea; TNF-Related Apoptosis-Inducing Ligand; Transcription Factor CHOP; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Green tea: cancer preventive beverage and/or drug.
Topics: Antineoplastic Agents; Beverages; Catechin; Humans; Neoplasms; Tea | 2002 |
Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions.
Topics: Animals; Antioxidants; Biological Availability; Biomarkers; Cardiovascular Diseases; Catechin; Chronic Disease; Flavonoids; Free Radical Scavengers; Humans; Neoplasms; Oxidative Stress; Phenols; Polymers; Reactive Oxygen Species; Tea | 2003 |
Tea and cancer prevention: studies in animals and humans.
Topics: Animals; Apoptosis; Caffeine; Catechin; Clinical Trials as Topic; Flavonoids; Humans; Lung Neoplasms; Mice; Mouth Neoplasms; Neoplasms; Phenols; Polyphenols; Rats; Smoking; Tea | 2003 |
Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Diet; Epidemiologic Methods; Estrogen Antagonists; Food; Genistein; Humans; Isoflavones; Neoplasms; Phytoestrogens; Plant Preparations | 2004 |
Nutraceuticals and cancer management.
Topics: Antioxidants; Capsaicin; Carotenoids; Catechin; Catechols; Complementary Therapies; Curcumin; Fatty Alcohols; Flavones; Genistein; Herbal Medicine; Humans; Isoflavones; Lycopene; Minerals; Neoplasms; Phytoestrogens; Phytotherapy; Plant Preparations; Vitamins | 2005 |
Trapping of growth factors by catechins: a possible therapeutical target for prevention of proliferative diseases.
Topics: Animals; Catechin; Cell Proliferation; ErbB Receptors; Growth Substances; Neoplasms; Platelet-Derived Growth Factor; Signal Transduction; Vascular Endothelial Growth Factor A | 2005 |
Green tea: Health benefits as cancer preventive for humans.
Topics: Antineoplastic Agents; Catechin; Epidemiologic Studies; Flavonoids; Humans; Hydrolyzable Tannins; Japan; Neoplasms; Phenols; Polyphenols; Tea; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2005 |
Breaking the relay in deregulated cellular signal transduction as a rationale for chemoprevention with anti-inflammatory phytochemicals.
Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Catechin; Diet; Humans; Inflammation; Molecular Structure; Neoplasms; Plants; Protein Kinases; Signal Transduction; Transcription Factors | 2005 |
Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Catechin; Humans; Inflammation; Mice; Neoplasms; NF-kappa B; Oxidation-Reduction; Oxidative Stress; Plant Extracts; Signal Transduction | 2005 |
Possible mechanisms of the cancer-preventive activities of green tea.
Topics: Animals; Caffeine; Catechin; DNA Modification Methylases; Enzyme Inhibitors; Humans; Neoplasms; Protein Kinase Inhibitors; Protein Kinases; Tea; Telomerase; Tetrahydrofolate Dehydrogenase | 2006 |
Intracellular signaling network as a prime chemopreventive target of (-)-epigallocatechin gallate.
Topics: Animals; Antioxidants; Apoptosis; Catechin; Cell Cycle; Cell Division; Chemoprevention; Humans; Inflammation; Metabolic Detoxication, Phase II; Neoplasm Metastasis; Neoplasms; Protein Kinases; Signal Transduction; Tea; Transcription Factors | 2006 |
Tea, hormone-related cancers and endogenous hormone levels.
Topics: Animals; Breast Neoplasms; Catechin; Female; Hormones; Humans; Male; Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Risk Factors; Tea | 2006 |
Dietary small molecules and large-scale gene expression studies: an experimental approach for understanding their beneficial effects on the development of malignant and non-malignant proliferative diseases.
Topics: Animals; Aryldialkylphosphatase; Catechin; Dietary Supplements; Gene Expression Regulation; Genomics; Humans; Neoplasms; Nutritional Physiological Phenomena; Proteomics; Signal Transduction | 2006 |
The roles of polyphenols in cancer chemoprevention.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Carcinogens; Catechin; Cell Communication; Cyclooxygenase Inhibitors; Diet; Flavonoids; Gap Junctions; Genistein; Humans; Matrix Metalloproteinases; Neoplasms; Oxidative Stress; Phenols; Polyphenols; Prostaglandin-Endoperoxide Synthases; Quercetin; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes | 2006 |
Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Catechin; Humans; Molecular Structure; Neoplasms; Skin; Tea | 2006 |
Lessons learned from Art Pardee in cell cycle, science, and life.
Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Cycle; Cell Death; Copper; Cyclins; Flavonoids; Gene Expression Regulation; Humans; Molecular Structure; Multiprotein Complexes; Neoplasms; Phenols; Polyphenols; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Research Personnel; Retinoblastoma Protein | 2006 |
Chemopreventive actions of polyphenolic compounds in cancer.
Topics: Animals; Antineoplastic Agents; Catechin; Flavonoids; Humans; Models, Biological; Molecular Structure; Neoplasms; NF-kappa B; Phenols; Polyphenols; Signal Transduction | 2006 |
Mechanisms of cancer prevention by green and black tea polyphenols.
Topics: Animals; Antioxidants; Apoptosis; Arachidonic Acid; Catechin; Cell Cycle; Cell Proliferation; fas Receptor; Flavonoids; Gene Expression; Humans; Lipid Peroxidation; Lipoproteins, LDL; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; NF-kappa B; Nitric Oxide; Oncogenes; Oxidation-Reduction; Phenols; Polyphenols; Proteasome Inhibitors; Reactive Oxygen Species; Receptors, Androgen; Receptors, Aryl Hydrocarbon; Receptors, Growth Factor; Tea; Telomere; Tetrahydrofolate Dehydrogenase | 2006 |
Dietary polyphenolic phytochemicals--promising cancer chemopreventive agents in humans? A review of their clinical properties.
Topics: Antineoplastic Agents, Phytogenic; Catechin; Clinical Trials, Phase III as Topic; Curcumin; Dietary Supplements; Flavonoids; Humans; Molecular Structure; Neoplasms; Phenols; Polyphenols | 2007 |
Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antioxidants; Catechin; Docosahexaenoic Acids; Gene Expression Profiling; Humans; Neoplasms; Retinoids; Selenium | 2006 |
The proteasome as a potential target for novel anticancer drugs and chemosensitizers.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Catechin; Clinical Trials as Topic; Curcumin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Genistein; Humans; Neoplasms; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Radiation-Sensitizing Agents; Resveratrol; Stilbenes; Structure-Activity Relationship; Ubiquitin | 2006 |
Tea and cancer prevention: molecular mechanisms and human relevance.
Topics: Animals; Anticarcinogenic Agents; Caffeine; Catechin; Humans; Molecular Structure; Neoplasms; Tea | 2007 |
Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.
Topics: Anticarcinogenic Agents; Antioxidants; Catechin; Cell Cycle; Confounding Factors, Epidemiologic; Humans; Neoplasms; Tea | 2007 |
Green tea polyphenols: biology and therapeutic implications in cancer.
Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Cell Proliferation; Flavonoids; Gene Expression Regulation; Humans; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Phenols; Polyphenols; Signal Transduction; Tea | 2007 |
Inhibition of carcinogenesis by tea constituents.
Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Transformation, Neoplastic; Disease Models, Animal; Flavonoids; Humans; Neoplasms; Phenols; Polyphenols; Tea | 2007 |
Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Catechin; Curcumin; Humans; Indoles; Neoplasms; Resveratrol; Stilbenes | 2007 |
Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate.
Topics: Anticarcinogenic Agents; Catechin; Humans; Mitogen-Activated Protein Kinases; Neoplasms; NF-kappa B; Signal Transduction; Tea; Transcription Factor AP-1 | 2007 |
Cell cycle control as a basis for cancer chemoprevention through dietary agents.
Topics: Animals; Anticarcinogenic Agents; Apigenin; Catechin; Cell Cycle; Cell Proliferation; Curcumin; Cyclin-Dependent Kinases; Diet; Genistein; Humans; Neoplasms; Resveratrol; Silymarin; Stilbenes; Tea | 2008 |
Putative cancer chemopreventive agents of dietary origin-how safe are they?
Topics: Antineoplastic Agents, Phytogenic; Capsaicin; Catechin; Chemoprevention; Consumer Product Safety; Curcumin; Diet; Humans; Indoles; Male; Neoplasms; Quercetin; Toxicity Tests | 2007 |
Multitargeted therapy of cancer by green tea polyphenols.
Topics: Anticarcinogenic Agents; Apoptosis; Biological Availability; Catechin; Cell Cycle; ErbB Receptors; Flavonoids; Humans; Insulin-Like Growth Factor I; MAP Kinase Signaling System; Matrix Metalloproteinase Inhibitors; Neoplasms; NF-kappa B; Phenols; Polyphenols; Signal Transduction; Tea; Transcription Factor AP-1; Urokinase-Type Plasminogen Activator | 2008 |
A new tumor promotion pathway and its inhibitors.
Topics: Anticarcinogenic Agents; Catechin; Cyclohexanols; Diterpenes; Ethers, Cyclic; Humans; Neoplasms; Okadaic Acid; Tumor Necrosis Factor-alpha | 1994 |
Dietary inhibitors against mutagenesis and carcinogenesis.
Topics: Anticarcinogenic Agents; Antimutagenic Agents; Carcinogenicity Tests; Catechin; Chlorophyll; Diet; Hemin; Humans; Mutagenicity Tests; Neoplasms; Risk Factors | 1993 |
Japanese green tea as a cancer preventive in humans.
Topics: Anticarcinogenic Agents; Catechin; Health Promotion; Humans; Japan; Neoplasms; Tea | 1996 |
Mechanistic findings of green tea as cancer preventive for humans.
Topics: Antineoplastic Agents; Catechin; Humans; Neoplasms; Plant Extracts; Receptors, Estrogen; Receptors, Progesterone; Tea; Tumor Necrosis Factor-alpha | 1999 |
Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances.
Topics: Animals; Capsaicin; Catechin; Catechols; Curcumin; Diet; Fatty Alcohols; Humans; Mice; Neoplasms; Neoplasms, Experimental; Phenols; Plants, Edible; Plants, Medicinal; Resveratrol; Stilbenes | 1999 |
Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer.
Topics: Catechin; Cell Division; Flavonoids; Humans; Neoplasms; Plant Extracts; Tea | 1999 |
Phytochemicals as modulators of cancer risk.
Topics: Anticarcinogenic Agents; Catechin; Estrogens, Non-Steroidal; Female; Humans; Indoles; Isoflavones; Isothiocyanates; Male; Neoplasms; Phytoestrogens; Plant Preparations; Plants, Edible; Risk Factors; Sulfoxides; Thiocyanates | 1999 |
A new concept of tumor promotion by tumor necrosis factor-alpha, and cancer preventive agents (-)-epigallocatechin gallate and green tea--a review.
Topics: Animals; Anticarcinogenic Agents; Biomarkers, Tumor; Carcinogens; Catechin; Humans; Incidence; Neoplasms; Tea; Tumor Necrosis Factor-alpha | 2000 |
Effects of food factors on signal transduction pathways.
Topics: Anticarcinogenic Agents; Apoptosis; Biflavonoids; Carcinogens; Catechin; Cell Transformation, Neoplastic; Food; Genes, Tumor Suppressor; Humans; Neoplasms; NF-kappa B; Signal Transduction; Transcription Factor AP-1; Tumor Suppressor Protein p53 | 2000 |
Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents.
Topics: Acetylcysteine; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Catechin; Flavonoids; Humans; Models, Biological; Neoplasms; Neovascularization, Pathologic; Protease Inhibitors; Receptors, Cytoplasmic and Nuclear | 2002 |
Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.
Topics: Angiogenesis Inhibitors; Anticarcinogenic Agents; Catechin; Humans; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Phytotherapy; Plant Extracts; Tea | 2001 |
[Cancer prevention with green tea: reality and wishful thinking].
Topics: Animals; Carcinogens; Catechin; Cell Transformation, Neoplastic; Humans; Neoplasms; Tea; Treatment Outcome | 2002 |
2 trial(s) available for epigallocatechin gallate and Benign Neoplasms
| Article | Year |
|---|---|
Efficacy and safety of epigallocatechin-3-gallate in treatment acute severe dermatitis in patients with cancer receiving radiotherapy: a phase I clinical trial.
Topics: Acute Disease; Catechin; Dermatitis; Humans; Neoplasms; Radiodermatitis | 2023 |
Critical need for clinical trials: an example of a pilot human intervention trial of a mixture of natural agents protecting lymphocytes against TNF-alpha induced activation of NF-kappaB.
Topics: Adult; Biological Products; Catechin; Curcumin; DNA; Female; Humans; Isoflavones; Lymphocytes; Male; Middle Aged; Neoplasms; NF-kappa B; Oxidative Stress; Tumor Necrosis Factor-alpha; Young Adult | 2010 |
79 other study(ies) available for epigallocatechin gallate and Benign Neoplasms
| Article | Year |
|---|---|
The lipogenesis pathway as a cancer target.
Topics: Acetyl-CoA Carboxylase; Animals; Antineoplastic Agents; ATP Citrate (pro-S)-Lyase; Biosynthetic Pathways; Fatty Acid Synthases; Fatty Acids; Humans; Lipogenesis; Models, Chemical; Molecular Structure; Neoplasms | 2011 |
Potent and Nontoxic Chemosensitizer of P-Glycoprotein-Mediated Multidrug Resistance in Cancer: Synthesis and Evaluation of Methylated Epigallocatechin, Gallocatechin, and Dihydromyricetin Derivatives.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Catechin; Cell Proliferation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavonols; Humans; Methylation; Models, Molecular; Molecular Structure; Neoplasm Proteins; Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2015 |
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
Topics: Aldehyde Reductase; Aldo-Keto Reductases; Apigenin; Daunorubicin; Enzyme Inhibitors; Flavones; Flavonoids; HCT116 Cells; Humans; Luteolin; Molecular Conformation; Molecular Structure; Neoplasms | 2015 |
Protective effects of kaempferol against reactive oxygen species-induced hemolysis and its antiproliferative activity on human cancer cells.
Topics: Antioxidants; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Erythrocytes; HeLa Cells; Hemolysis; Humans; Kaempferols; MCF-7 Cells; Molecular Structure; Neoplasms; Protective Agents; Reactive Oxygen Species; Structure-Activity Relationship | 2016 |
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Biological Availability; Drug Delivery Systems; Humans; Neoplasms; Phytochemicals; Polyphenols | 2017 |
Antioxidant and pro-apoptotic effects of marine-derived, multi-mineral aquamin supplemented with a pine bark extract, Enzogenol, and a green tea extract, Sunphenon.
Topics: Antioxidants; Apoptosis; Camellia sinensis; Dietary Supplements; Flavonoids; Humans; Minerals; Neoplasms; Phenols; Pinus; Plant Bark; Plant Extracts; Quercetin; Rhodophyta; U937 Cells | 2013 |
Epigallocatechin‑3‑gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancer‑associated fibroblasts.
Topics: Cancer-Associated Fibroblasts; Catechin; Colorectal Neoplasms; Humans; Neoplasms; Oxidative Coupling; Warburg Effect, Oncologic | 2022 |
Engineered EGCG-Containing Biomimetic Nanoassemblies as Effective Delivery Platform for Enhanced Cancer Therapy.
Topics: B7-H1 Antigen; Biomimetics; Catechin; Cell Line, Tumor; Immunologic Factors; Immunotherapy; Neoplasms | 2022 |
Single-step assembly of lipid-gelatin-epigallocatechin-3-gallate hybrid nanoparticles for cancer therapy.
Topics: Animals; Catechin; Drug Carriers; Gelatin; Lipids; Mice; Nanoparticles; Neoplasms | 2023 |
(-)-Epigallocatechin-3-Gallate Attenuates the Adverse Reactions Triggered by Selenium Nanoparticles without Compromising Their Suppressing Effect on Peritoneal Carcinomatosis in Mice Bearing Hepatocarcinoma 22 Cells.
Topics: Animals; Catechin; Diarrhea; Mice; Nanoparticles; Neoplasms; Polyphenols; Selenium; Tea | 2023 |
Natural Moieties as Anti-Inflammatory Agents-Recent Patents.
Topics: Animals; Anti-Inflammatory Agents; Apigenin; Biological Products; Cardiovascular Diseases; Catechin; Coumaric Acids; Humans; Inflammation; Neoplasms; Neurodegenerative Diseases; Patents as Topic; Plants; Polyphenols; Quercetin | 2019 |
A Metal-Polyphenol-Coordinated Nanomedicine for Synergistic Cascade Cancer Chemotherapy and Chemodynamic Therapy.
Topics: Animals; Antineoplastic Agents; Catechin; Cisplatin; Hep G2 Cells; Humans; Mice; Nanomedicine; Nanoparticles; Neoplasms; Polyphenols; Prodrugs; Reactive Oxygen Species | 2020 |
An intelligent nanodevice based on the synergistic effect of telomerase-triggered photodynamic therapy and gene-silencing for precise cancer cell therapy.
Topics: Catechin; Cell Line, Tumor; Cell Survival; Chlorophyllides; DNA; DNA, Catalytic; Gene Silencing; Humans; Light; Manganese Compounds; Nanostructures; Neoplasms; Oxides; Photochemotherapy; Photosensitizing Agents; Porphyrins; RNA, Messenger; Survivin; Telomerase | 2020 |
Preparation of Strong Antioxidative, Therapeutic Nanoparticles Based on Amino Acid-Induced Ultrafast Assembly of Tea Polyphenols.
Topics: Amino Acids; Animals; Antioxidants; Catechin; Cell Line, Tumor; Cell Survival; Female; Indoles; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Particle Size; Polymers; Polyphenols; Tea; Tissue Distribution; Transplantation, Homologous | 2020 |
General Nanomedicine Platform by Solvent-Mediated Disassembly/Reassembly of Scalable Natural Polyphenol Colloidal Spheres.
Topics: Animals; Catechin; Cell Survival; Doxorubicin; Drug Carriers; Female; Humans; Hydrophobic and Hydrophilic Interactions; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanomedicine; Nanoparticles; Neoplasms; Polyphenols; Solvents; Transplantation, Heterologous | 2020 |
EGCG sensitizes chemotherapeutic-induced cytotoxicity by targeting the ERK pathway in multiple cancer cell lines.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Catechin; Cytotoxins; HT29 Cells; Humans; MAP Kinase Signaling System; Neoplasms | 2020 |
Novel Perbutyrylated Glucose Derivatives of (-)-Epigallocatechin-3-Gallate Inhibit Cancer Cells Proliferation by Decreasing Phosphorylation of the EGFR: Synthesis, Cytotoxicity, and Molecular Docking.
Topics: A549 Cells; Antineoplastic Agents; Catechin; Cell Proliferation; Cytotoxins; ErbB Receptors; Glucose; HL-60 Cells; Humans; MCF-7 Cells; Molecular Docking Simulation; Neoplasm Proteins; Neoplasms; Phosphorylation | 2021 |
Studies on the non-invasive anticancer remedy of the triple combination of epigallocatechin gallate, pulsed electric field, and ultrasound.
Topics: Apoptosis; Autophagy; Caspases; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Humans; Neoplasms; Pulsed Radiofrequency Treatment; Reactive Oxygen Species; Ultrasonic Therapy; Ultrasonic Waves | 2018 |
Coordination microparticle vaccines engineered from tumor cell templates.
Topics: Actin Cytoskeleton; Aluminum; Animals; Cancer Vaccines; Catechin; Cell Line, Tumor; Cell Survival; Clathrin; Coordination Complexes; Dendritic Cells; Endocytosis; Mice; Microscopy, Confocal; Neoplasms; Transplantation, Homologous | 2019 |
Tea's value as a cancer therapy is steeped in uncertainty.
Topics: Animals; Biological Products; Case-Control Studies; Catechin; Cell Line, Tumor; China; Cohort Studies; Dietary Supplements; Disease Models, Animal; Female; Humans; Incidence; Japan; Life Style; Male; Metabolic Syndrome; Mice; Neoplasms; Plant Extracts; Prostatic Neoplasms; Sex Factors; Smoking; Sunitinib; Tea; Uncertainty | 2019 |
A novel role of HuR in -Epigallocatechin-3-gallate (EGCG) induces tumour cells apoptosis.
Topics: ADAM10 Protein; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Apoptosis; bcl-2-Associated X Protein; Catechin; ELAV-Like Protein 1; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; MAP Kinase Signaling System; Membrane Proteins; Neoplasms; PC12 Cells; Proto-Oncogene Proteins c-bcl-2; Rats | 2019 |
In Silico Investigation of the Anti-Tumor Mechanisms of Epigallocatechin-3-Gallate.
Topics: Antineoplastic Agents; Catechin; Computer Simulation; Humans; Neoplasms; Proteins; Signal Transduction; Tea | 2019 |
Spectroscopic and cytotoxicity studies on the combined interaction of (-)-epigallocatechin-3-gallate and anthracycline drugs with human serum albumin.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Catechin; Cell Survival; Circular Dichroism; Doxorubicin; Entropy; Epirubicin; HeLa Cells; Humans; Neoplasms; Protein Binding; Serum Albumin, Human; Spectrometry, Fluorescence | 2019 |
A Generic Coordination Assembly-Enabled Nanocoating of Individual Tumor Cells for Personalized Immunotherapy.
Topics: Animals; Antigens; Body Weight; Bone Marrow Cells; Catechin; Cell Line, Tumor; Cell Survival; Dendritic Cells; Female; Humans; Immunotherapy; Lung Neoplasms; Mice, Inbred C57BL; Nanoparticles; Neoplasms; Photoelectron Spectroscopy; Precision Medicine | 2019 |
Melatonin and (-)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer.
Topics: Anticarcinogenic Agents; Catechin; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p21; Hep G2 Cells; Humans; Melatonin; Neoplasms | 2019 |
DNA-templated porous nanoplatform towards programmed "double-hit" cancer therapy via hyperthermia and immunogenicity activation.
Topics: Animals; Catechin; Cobalt; DNA; Drug Delivery Systems; Drug Liberation; HCT116 Cells; HSP90 Heat-Shock Proteins; Humans; Hyperthermia, Induced; Magnetic Resonance Imaging; Mice; Nanoparticles; Neoplasms; Oxaliplatin; Phototherapy; Porosity; Tissue Distribution | 2019 |
Inducing apoptosis of cancer cells using small-molecule plant compounds that bind to GRP78.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Catechin; Cell Line, Tumor; Cell Survival; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Heat-Shock Proteins; Humans; Lignans; Molecular Targeted Therapy; Molecular Weight; Neoplasms; Protein Binding | 2013 |
Cellular targets for the beneficial actions of tea polyphenols.
Topics: Animals; Antioxidants; Biflavonoids; Camellia sinensis; Catechin; Humans; Neoplasms; Oxidants; Phytotherapy; Plant Extracts; Polyphenols; Signal Transduction; Tea | 2013 |
Inhibitory activity of synthesized acetylated Procyanidin B1 analogs against HeLa S3 cells proliferation.
Topics: Acetylation; Biflavonoids; Catechin; Cell Proliferation; HeLa Cells; Humans; Neoplasms; Polymers; Proanthocyanidins; Tea | 2014 |
Immunoprotective effect of epigallocatechin-3-gallate on oral anticancer drug-induced α-defensin reduction in Caco-2 cells.
Topics: alpha-Defensins; Antimetabolites, Antineoplastic; Antioxidants; Caco-2 Cells; Catechin; Herb-Drug Interactions; Humans; Hydrogen Peroxide; Intestinal Mucosa; Neoplasms; Plant Extracts; Reactive Oxygen Species; RNA, Messenger; Tegafur | 2014 |
Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Drug Carriers; Humans; Mice; Mice, Nude; Micelles; Neoplasms; Trastuzumab | 2014 |
Alternative approaches to Hsp90 modulation for the treatment of cancer.
Topics: Animals; Antineoplastic Agents; Catechin; Drug Discovery; HSP90 Heat-Shock Proteins; Humans; Models, Molecular; Neoplasms; Novobiocin; Silybin; Silymarin | 2014 |
Chemopreventive potential of the tannase-mediated biotransformation of green tea.
Topics: Antioxidants; Biotransformation; Camellia sinensis; Carboxylic Ester Hydrolases; Catechin; Chemoprevention; Comet Assay; Humans; Neoplasms; Plant Extracts | 2012 |
Incubator proof miniaturized Holomonitor to in situ monitor cancer cells exposed to green tea polyphenol and preosteoblast cells adhering on nanostructured titanate surfaces: validity of the measured parameters and their corrections.
Topics: Animals; Catechin; Cell Adhesion; Cell Line; Cell Movement; HeLa Cells; Holography; Humans; Mice; Microscopy; Nanostructures; Neoplasms; Reproducibility of Results; Single-Cell Analysis; Tea; Titanium | 2015 |
Quantitative Evaluation of Cancer Cell Adhesion to Self-Assembled Monolayer-Patterned Substrates by Reflection Interference Contrast Microscopy.
Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Adhesion; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Melanoma, Experimental; Mice; Microscopy, Interference; Neoplasm Metastasis; Neoplasms | 2016 |
Chemoprevention of dibenzo[a,l]pyrene transplacental carcinogenesis in mice born to mothers administered green tea: primary role of caffeine.
Topics: Animals; Anticarcinogenic Agents; Benzopyrenes; Caffeine; Carcinogens; Catechin; Chemoprevention; Female; Maternal-Fetal Exchange; Mice; Neoplasms; Placenta; Plant Extracts; Pregnancy; Tea | 2008 |
Can drinking tea prevent cancer? A controversy revisited.
Topics: Anticarcinogenic Agents; Catechin; Flavonoids; Humans; Neoplasms; Phenols; Polyphenols; Tea | 2009 |
50 Hz extremely low frequency electromagnetic fields enhance protein carbonyl groups content in cancer cells: effects on proteasomal systems.
Topics: Analysis of Variance; Caco-2 Cells; Carcinogens; Catechin; Cell Survival; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Radiation; Electromagnetic Fields; Humans; Neoplasms; Proteasome Endopeptidase Complex; Protein Carbonylation; Radiation-Protective Agents; Temperature; Tetradecanoylphorbol Acetate | 2009 |
Nanochemoprevention by bioactive food components: a perspective.
Topics: Animals; Anticarcinogenic Agents; Catechin; Chemoprevention; Humans; Nanoparticles; Nanotechnology; Neoplasms | 2010 |
Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats.
Topics: Aldehydes; Animals; Antineoplastic Agents; Antioxidants; Catalase; Catechin; Cisplatin; Glutathione; Glutathione Peroxidase; Heme Oxygenase-1; Kidney; Male; Neoplasms; NF-E2-Related Factor 2; NF-kappa B; Rats; Rats, Wistar; Signal Transduction; Superoxide Dismutase; Tea | 2010 |
Nutraceutical inhibition of muscle proteolysis: a role of diallyl sulphide in the treatment of muscle wasting.
Topics: Allyl Compounds; Animals; Anorexia; Cachexia; Catechin; Cells, Cultured; Dietary Supplements; Genistein; Male; Muscle, Skeletal; Muscular Atrophy; Neoplasms; Rats; Rats, Wistar; Resveratrol; Stilbenes; Sulfides; Weight Loss | 2011 |
Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines.
Topics: Antineoplastic Agents, Phytogenic; Ascorbic Acid; Camellia sinensis; Catechin; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Lysine; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Micronutrients; Neoplasm Invasiveness; Neoplasms; Plant Extracts; Proline; Protease Inhibitors; Tetradecanoylphorbol Acetate | 2010 |
Cytotoxicity of arsenic trioxide is enhanced by (-)-epigallocatechin-3-gallate via suppression of ferritin in cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caffeic Acids; Catechin; Cell Line, Tumor; Cytotoxins; Drug Synergism; Ferritins; Heme Oxygenase (Decyclizing); HL-60 Cells; Humans; Neoplasms; Oxides; Phenylethyl Alcohol | 2011 |
Targeting the unfolded protein response in cancer therapy.
Topics: Animals; Antineoplastic Agents; Catechin; Cell Line; Drug Screening Assays, Antitumor; Endoplasmic Reticulum Chaperone BiP; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Heat-Shock Proteins; Humans; Neoplasms; Thapsigargin; Unfolded Protein Response | 2011 |
Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro.
Topics: Animals; Antimetabolites, Antineoplastic; Area Under Curve; Camellia sinensis; Catechin; Cell Line, Tumor; Cell Survival; Drug Synergism; Fluorouracil; Humans; Male; Neoplasms; Plant Extracts; Rats; Rats, Sprague-Dawley | 2011 |
Nicotinic acetylcholine receptor-based blockade: applications of molecular targets for cancer therapy.
Topics: Aconitine; Anticarcinogenic Agents; Catechin; Humans; Molecular Targeted Therapy; Neoplasms; Nicotinic Antagonists; Receptors, Nicotinic; Signal Transduction; Smoking; Terpenes | 2011 |
Green tea gets molecular.
Topics: Animals; Anticarcinogenic Agents; Catechin; Fibroblasts; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Knockout; Models, Chemical; Neoplasms; NF-kappa B; NIMA-Interacting Peptidylprolyl Isomerase; Peptidylprolyl Isomerase; Tea; Transcription Factor AP-1; Transcription, Genetic | 2011 |
Epigallocatechin gallate (EGCG) inhibits type II phosphatidylinositol 4-kinases: a key component in pathways of phosphoinositide turnover.
Topics: 1-Phosphatidylinositol 4-Kinase; Amino Acid Sequence; Anticarcinogenic Agents; Binding Sites; Camellia sinensis; Catechin; Enzyme Inhibitors; Humans; Jurkat Cells; Models, Molecular; Molecular Sequence Data; Neoplasms; Phosphatidylinositols; Protein Binding; Protein Isoforms; Sequence Alignment | 2011 |
Comment on the special issue--green tea and cancer.
Topics: Catechin; Humans; Neoplasms; Tea | 2011 |
Complementary therapies, herbs, and other OTC agents: Green tea (Camellia sinensis).
Topics: Anticarcinogenic Agents; Camellia sinensis; Catechin; Herb-Drug Interactions; Neoplasms; Phytotherapy; Plant Extracts; Plant Leaves | 2011 |
Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo.
Topics: Animals; Biological Availability; Catechin; Catechol O-Methyltransferase; Cell Line, Tumor; Down-Regulation; Humans; Male; Methylation; Mice; Mice, SCID; Neoplasms; Polyphenols; Quercetin; Tea; Up-Regulation | 2012 |
Selective death of cancer cells by preferential induction of reactive oxygen species in response to (-)-epigallocatechin-3-gallate.
Topics: Antineoplastic Agents; Apoptosis; Catechin; Cyclin-Dependent Kinase Inhibitor p21; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; HCT116 Cells; HEK293 Cells; Humans; Neoplasms; Reactive Oxygen Species; Telomerase; Tumor Suppressor Protein p53; Up-Regulation | 2012 |
Synergetic downregulation of 67 kDa laminin receptor by the green tea (Camellia sinensis) secondary plant compound epigallocatechin gallate: a new gateway in metastasis prevention?
Topics: Animals; Camellia sinensis; Catechin; Cell Line; Down-Regulation; Humans; Neoplasm Metastasis; Neoplasms; Plant Extracts; Receptors, Laminin | 2012 |
67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis.
Topics: Animals; Apoptosis; Caspases; Catechin; Cell Line, Tumor; Cell Proliferation; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Humans; Imidazoles; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Molecular Weight; Multiple Myeloma; Neoplasms; Phosphodiesterase 5 Inhibitors; Piperazines; Receptors, Laminin; Signal Transduction; Sulfones; Triazines; Vardenafil Dihydrochloride; Xenograft Model Antitumor Assays | 2013 |
Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells.
Topics: Antioxidants; Bromodeoxyuridine; Catalase; Catechin; Epithelial Cells; Flavonoids; Humans; Neoplasms; Oxidative Stress; Phenols; Polymers; Reactive Oxygen Species; Superoxide Dismutase; Tea; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2003 |
Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture.
Topics: Animals; Anticarcinogenic Agents; Caffeine; Catechin; Chemoprevention; Curcumin; Enzyme Induction; Enzyme Inhibitors; Humans; Neoplasms | 2003 |
Induction of apoptosis by EGCG in selected tumour cell lines in vitro.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Catechin; Cell Line; Cell Line, Tumor; Comet Assay; Dose-Response Relationship, Drug; Humans; Neoplasms | 2003 |
Green tea polyphenols: antioxidative and prooxidative effects.
Topics: Animals; Antioxidants; Catechin; Drug Stability; Flavonoids; Humans; Neoplasms; Oxidants; Phenols; Polyphenols; Tea; Tumor Cells, Cultured | 2004 |
Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression.
Topics: Aorta; Atherosclerosis; Blotting, Northern; Blotting, Western; Catechin; Cell Movement; Cells, Cultured; Gene Expression; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Muscle, Smooth, Vascular; Neoplasms; Tea; Thrombin | 2005 |
Inhibition of survival signalling by dietary polyphenols and indole-3-carbinol.
Topics: Apoptosis; Catechin; Cell Cycle; Curcumin; Flavonoids; Humans; Indoles; Mitogen-Activated Protein Kinases; Neoplasms; NF-kappaB-Inducing Kinase; Phenols; Polyphenols; Protein Serine-Threonine Kinases; Signal Transduction; STAT Transcription Factors | 2005 |
Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.
Topics: Catechin; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Neoplasms; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Signal Transduction; Tea; Umbilical Veins; Vascular Endothelial Growth Factor A | 2006 |
Use of cancer chemopreventive phytochemicals as antineoplastic agents.
Topics: Antineoplastic Agents, Phytogenic; Catechin; Curcumin; Humans; Neoplasms | 2005 |
Dietary factors may modify cancer risk by altering xenobiotic metabolism and many other mechanisms.
Topics: Animals; Catechin; Cells, Cultured; Diet; Humans; Neoplasms; Risk Factors; Xenobiotics | 2006 |
Mouse embryonic fibroblast cells from transgenic mice overexpressing tNOX exhibit an altered growth and drug response phenotype.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Shape; Cells, Cultured; Embryo, Mammalian; Female; Fibroblasts; Isoflavones; Male; Mice; Mice, Transgenic; NADH, NADPH Oxidoreductases; Neoplasms; Oxidation-Reduction; Phenotype | 2007 |
Chemotherapy enhances CD8(+) T cell-mediated antitumor immunity induced by vaccination with vaccinia virus.
Topics: Animals; Antineoplastic Agents; Catechin; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cyclophosphamide; Female; Lysosomal-Associated Membrane Protein 1; Mice; Mice, Inbred C57BL; Neoplasms; Papillomavirus E7 Proteins; Protein Sorting Signals; Vaccination; Vaccinia virus | 2007 |
The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells.
Topics: Anticarcinogenic Agents; Apoptosis; Camellia sinensis; Catechin; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Neoplasms; Plant Extracts; Telomerase | 2007 |
Characterizing the spatio-temporal behavior of cell populations through image auto- and cross-correlation microscopy.
Topics: Animals; Catechin; Cell Aggregation; Cell Line; Cell Movement; Cell Survival; Cells; Computer Simulation; Humans; Image Processing, Computer-Assisted; Mice; Microscopy; Neoplasms; Time Factors | 2007 |
Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Curcumin; Diet; DNA Damage; Gene Expression Regulation, Neoplastic; Genistein; Humans; Indoles; Neoplasm Proteins; Neoplasms; RNA, Neoplasm; Time Factors | 2007 |
Green tea catechin as a chemical chaperone in cancer prevention.
Topics: Catechin; Molecular Chaperones; Neoplasms; Protein Conformation | 2008 |
Clinical development plan: tea extracts. Green tea polyphenols. Epigallocatechin gallate.
Topics: Animals; Anticarcinogenic Agents; Catechin; Dogs; Drug Approval; Female; Flavonoids; Humans; Male; Mice; Neoplasms; Neoplasms, Experimental; Phenols; Plant Extracts; Polymers; Rats; Research Design; Tea | 1996 |
Why drinking green tea could prevent cancer.
Topics: Animals; Anticarcinogenic Agents; Catechin; Computer Simulation; Enzyme Inhibitors; Humans; Neoplasms; Tea; Urokinase-Type Plasminogen Activator | 1997 |
Cancer inhibition by green tea.
Topics: 3T3 Cells; Animals; Anticarcinogenic Agents; Biological Availability; Catechin; Female; Humans; Male; Mice; Neoplasms; Tea; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1998 |
Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins.
Topics: Adenocarcinoma; Antineoplastic Agents; beta-Galactosidase; Catechin; Cell-Free System; Cellular Senescence; Colonic Neoplasms; Enzyme Inhibitors; Humans; Kinetics; Leukemia, Monocytic, Acute; Neoplasms; Tea; Telomerase; Telomere; Tumor Cells, Cultured | 1998 |
Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts.
Topics: Anticarcinogenic Agents; Apoptosis; Breast; Breast Neoplasms; Catechin; Cell Division; Cell Line, Transformed; Cells, Cultured; Colon; Colonic Neoplasms; Female; Fibroblasts; Gene Expression; Genes, fos; Genes, myc; Humans; Microscopy, Fluorescence; Neoplasms; RNA, Messenger; Tea; Tumor Cells, Cultured | 1998 |
Green tea and cancer chemoprevention.
Topics: 3T3 Cells; Animals; Apoptosis; Biological Availability; Breast Neoplasms; Case-Control Studies; Catechin; Drug Synergism; Female; Humans; Japan; Male; Mice; Neoplasms; Sulindac; Tea; Tissue Distribution; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1999 |
Two stages of cancer prevention with green tea.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Division; Cohort Studies; Drug Synergism; Female; Humans; Kava; Male; Neoplasms; Phytotherapy; Plants, Medicinal; Prospective Studies; Sulindac; Tea; Tissue Distribution; Tumor Necrosis Factor-alpha | 1999 |
Green tea experiments in lab, clinic yield mixed results.
Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Antioxidants; Beverages; Catechin; China; Clinical Trials as Topic; Endothelial Growth Factors; Flavonoids; Humans; Lymphokines; Neoplasms; Phenols; Phytotherapy; Polymers; Randomized Controlled Trials as Topic; Tea; Treatment Outcome; United States; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Role of antimutagens/anticarcinogens in cancer prevention.
Topics: Anticarcinogenic Agents; Antimutagenic Agents; Antioxidants; Catechin; Drug Resistance, Microbial; Escherichia coli; Histidine; Mutagenicity Tests; Mutation; Neoplasms; Salmonella typhimurium; Tea | 2000 |
Apoptosis-inducing activity of high molecular weight fractions of tea extracts.
Topics: Apoptosis; Catechin; DNA Fragmentation; Humans; Molecular Weight; Neoplasms; Plant Extracts; Stomach Neoplasms; Tea; Tumor Cells, Cultured; U937 Cells | 2001 |